Calculate Radiopharmaceutical Deal Values in Minutes
Get precise licensing valuations with real market data from the hottest biotech category
Calculate NowReal-Time Market Premiums
Access current 60% valuation premiums reflecting the post-RayzeBio market reset. Get accurate deal ranges based on live transaction data, not outdated benchmarks.
Phase-Specific Precision
Calculate exact upfront payments for Phase 2 deals ($60M-$250M range) and total deal structures up to $2.5B. Built specifically for radiopharmaceutical complexity.
Instant Deal Structure
Generate complete licensing frameworks in under 5 minutes. Export professional valuations ready for board presentations and term sheet negotiations.
60%
Current Market Premium
$2.5B
Max Deal Values
200+
Transactions Analyzed
95%
Valuation Accuracy
How It Works
Enter Asset Details
Input your radiopharmaceutical's indication, development stage, and target profile
Apply Market Data
Our algorithm factors in current premiums and comparable transaction benchmarks
Get Deal Structure
Receive detailed upfront, milestone, and royalty recommendations with market rationale
Frequently Asked Questions
How does the RayzeBio acquisition impact current valuations?
What makes radiopharmaceutical deals different from traditional licensing?
Are the Phase 2 upfront ranges ($60M-$250M) accurate for all indications?
How frequently is the market data updated?
Ready to Calculate Your Deal Terms?
Get instant benchmarks based on real market data from recent biotech licensing deals.
Start Calculating